Andrew Retter is Chief Medical Officer of VOLITIONRX LTD. Currently has a direct ownership of 127,475 shares of VNRX, which is worth approximately $71,386. The most recent transaction as insider was on Dec 01, 2024, when has been sold 9,365 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K
7.93% 3M change
n/a 12M change
Total Value Held $71,386

Andrew Retter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2024
BUY
Grant, award, or other acquisition
-
9,365 Added 6.84%
127,475 Common Stock
Sep 01 2024
BUY
Grant, award, or other acquisition
-
9,784 Added 7.65%
118,110 Common Stock
Jun 01 2024
BUY
Grant, award, or other acquisition
-
8,326 Added 7.14%
108,326 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock
AR

Andrew Retter

Chief Medical Officer
Henderson, NV

Track Institutional and Insider Activities on VNRX

Follow VOLITIONRX LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX